IPO Access & Alpha Generation
Institutional IPO Access for Qualified Investors
Strata's ECM relationships with Goldman Sachs, J.P. Morgan, Morgan Stanley, and Bank of America provide priority allocation to high-demand technology IPOs — access typically reserved for the largest institutional accounts.
As an LP in Strata, you gain exposure to upcoming high-demand technology IPOs — participating in day-one allocations across AI, quantum computing, and deep-tech public offerings before they reach the secondary market.
While IPO allocations are never guaranteed, Strata is well positioned to selectively indicate on the most compelling offerings — leveraging its proprietary quantitative research capabilities and long-standing ECM relationships to identify and pursue optimal entry points.
19
IPO Participations
60%
Public Allocation
15
Unicorns Backed
27.5%
IRR Across Vehicles
The Opportunity
Strata by Venture Science
A San Francisco Bay Area-based evergreen fund that combines venture capital access to transformative deep-tech companies with the liquidity of public market and IPO exposure — backed by a decade of decision-science-driven investing and track record.
Strata is built on the belief that the most attractive risk-adjusted returns in the coming decade will come from flexible capital deployed across both private and public markets—without the constraints of legacy fund structures.
Traditional funds are siloed, illiquid, and often misaligned with modern investor needs. Strata rethinks this model. By combining an evergreen structure with the ability to invest across the capital spectrum, we give investors exposure to high-conviction opportunities—whether that's a breakout startup or a mispriced public asset—while preserving the optionality to reallocate or redeem capital through structured windows.
We designed Strata for long-term partners who want access, transparency, and flexibility—without sacrificing performance or discipline. It's a modern vehicle for a more dynamic market environment.
Investment Thesis
Why IPOs Are a Core Alpha Source
Most investors access IPOs through secondary-market purchases after listing — paying a premium for shares that institutional allocators received at a discount. Strata inverts this dynamic by participating directly in the syndicate process.
Allocation-to-Listing Alpha Gap
The most significant pricing inefficiency in public markets occurs between institutional IPO allocation and first-day trading. Banks allocate shares at a discount to expected market price, creating a structural alpha opportunity for investors with syndicate access. Most investors are excluded entirely — this gap is captured by those with established ECM relationships.
Relationship-Driven Access
IPO allocation is not a market — it is a relationship. Banks prioritize their largest institutional clients, routing the most in-demand offerings to accounts with long-standing syndicate participation. Strata's decade-long ECM relationships with Goldman Sachs, J.P. Morgan, Morgan Stanley, and Bank of America provide access to allocations that are structurally unavailable to most funds and virtually all individual investors.
Full-Cycle Participation
Strata's hybrid structure enables full-cycle participation: identifying companies at the private stage, building conviction through pre-IPO diligence, securing day-one allocation through ECM channels, and managing post-IPO positions through lockup and beyond. This private-to-public continuity provides an information and timing advantage that pure public-market funds cannot replicate.
Proven IPO Execution
IPO Track Record
Strata has successfully navigated four portfolio companies through IPO, demonstrating consistent access to institutional syndicate allocations and full-cycle execution from private investment through public listing.
The positions below were held by other Venture Science funds and SPVs, not by Venture Science Strata Fund LP. They are shown to illustrate the firm's prior participation in initial public offerings and are not Strata's performance.
Circle Internet Financial
NYSE: CRCL · June 2025
We acquired our position in 2018. The company went public in June 2025, raising $1B at a valuation that represented a 16x price multiple, entry to IPO.* Shares doubled on debut.
Co-investors: Goldman Sachs, BlackRock, Sequoia Capital
Lyft
NASDAQ: LYFT
Early-stage investment in the transportation platform. IPO represented a significant liquidity event, demonstrating Strata's ability to identify and hold through the full private-to-public cycle.
Co-investors: Andreessen Horowitz, Founders Fund, Alphabet
Lemonade
NYSE: LMND
AI-driven insurtech company. Strata's position captured the private-to-public transition, with day-one trading reflecting the allocation-to-listing alpha thesis.
Co-investors: SoftBank, Sequoia Capital, Allianz
*16x increase in share price from the 2018 entry price to the June 2025 IPO price, before fees and expenses, as a multiple of price rather than a realized return.
Syndicate IPO Allocations
Beyond core portfolio IPOs, Strata's ECM relationships provide access to high-demand syndicate allocations across technology sectors. The following represents a sample of Venture Science prior funds' executed IPO allocations through institutional book-building. Allocations received by other Venture Science funds through syndicate relationships. Returns shown are first-day closing price versus offering price, are not realized returns, and are before fees and expenses.
Company
Ticker
IPO Date
Result
Airbnb
ABNB
Dec 2020
+104.87%
Upstart
UPST
Dec 2020
+31.60%
RDDT
Mar 2024
+45.68%
Xometry
XMTR
Jun 2021
+96.17%
monday.com
MNDY
Jun 2021
+33.85%
LifeStance Health
LFST
Jun 2021
+45.56%
Paymentus Holdings
PAY
May 2021
+38.10%
VTEX
VTEX
Jul 2021
+36.84%
Procore Technologies
PCOR
May 2021
+34.33%
Alkami Technology
ALKT
Apr 2021
+20.20%
Olo
OLO
Mar 2021
+20.00%
DoubleVerify
DV
Apr 2021
+13.85%
Core & Main
CNM
Jul 2021
+12.65%
Marqeta
MQ
Jun 2021
+10.82%
Global-e Online
GLBE
May 2021
+8.00%
Past performance is not indicative of future results. Strata did not hold these positions. There is no guarantee that Strata will receive an allocation in the Anthropic offering or in any other offering, or that any allocation it receives will perform similarly.
Active Pipeline
Multiple portfolio companies are currently in pre-IPO positioning across AI infrastructure, quantum computing, and commercial space sectors. Strata's ECM relationships are actively engaged for upcoming syndicate participation. Specific company details are available under NDA.
Institutional Infrastructure
How Strata Accesses IPOs
Strata's IPO access infrastructure mirrors the capabilities of endowments and sovereign wealth funds — institutional-grade syndicate participation powered by decade-long ECM relationships.
ECM Relationship
Strata maintains active syndicate relationships with Goldman Sachs, J.P. Morgan, Morgan Stanley, and Bank of America. These relationships are cultivated over years of consistent participation and provide priority access to IPO deal flow.
Indication of Interest
When a target company files for IPO, Strata's investment team evaluates the offering and submits an indication of interest through the lead bookrunner. Pre-existing private positions provide an informational advantage in sizing and conviction.
Book Building & Allocation
During the book-building process, Strata engages directly with the syndicate desk to communicate allocation preferences. Priority allocation is determined by the strength and history of the institutional relationship — not order size alone.
Day-One Position
On pricing night, Strata receives its institutional allocation at the IPO price — typically below expected opening-day trading levels. This allocation-to-listing gap represents the core alpha capture mechanism.
Post-IPO Management
Bank of America Merrill Lynch supports post-IPO execution including lockup expiration management and block trades. Strata's hybrid structure allows flexible position management across the public holding period.
ECM Partners
Goldman Sachs · J.P. Morgan · Morgan Stanley · Bank of America Merrill Lynch
Market Environment
The Late-2026 IPO Pipeline
The technology IPO pipeline has moved from anticipation to filings. Strata's ECM relationships and existing portfolio positions provide a way to evaluate the most closely watched offerings of the cycle as they come to market.
From Anticipation to Filings
Anthropic filed its Form S-1 publicly on October 26, 2026 and an amended S-1/A on November 2, 2026. The registration statement is not yet effective, and the number of shares, price range and offering size have not been set. Strata's assessment is published in Anthropic IPO: An MCDA Assessment.
Disciplined Evaluation, Not Participation by Default
Each prospective offering is assessed on its filed disclosures — economics, commitments, governance and valuation — before any allocation request is made. A closely watched listing is not automatically an attractive one.
The Hybrid Advantage
Strata's hybrid structure — combining private portfolio companies approaching IPO with institutional allocation access — provides a differentiated entry point that pure venture or pure public-market funds cannot offer.
Positioning: Strata holds active positions in pre-IPO companies across AI, quantum computing and commercial space, supported by ECM syndicate relationships with Goldman Sachs, J.P. Morgan, Morgan Stanley and BofA Securities.
Important Disclosure: There is no guarantee that Strata or any affiliated vehicle will receive allocations in any initial public offering, including SpaceX, Anthropic or any other specific company. IPO allocations are determined solely by the underwriting syndicate and are subject to demand, eligibility, and other factors outside the Fund's control. Past receipt of IPO allocations does not ensure future access. The mention of any company name does not constitute a recommendation or indication that an investment will be made or that an allocation will be received.
Investment Philosophy
Built for the Next Decade of Deep Tech
Strata is built on the belief that the next decade of alpha generation will come from the intersection of public-market liquidity and private-market innovation. We combine active participation in public offerings and liquid technology equities with selective investments in high-conviction private companies—particularly in AI, quantum computing, and deep tech.
Our approach applies institutional rigor to frontier technology investing. By operating as an evergreen fund with an annual redemption window, Strata offers investors long-term exposure to innovation with the transparency, liquidity, and flexibility that modern allocators demand.
Balancing Risk and Return
Venture
With a long-term perspective, venture investments can lead to substantial appreciation and potential tax benefits, enhancing overall portfolio resilience against market volatility.
IPO + Public Equities
This combination allows investors to benefit from startup growth and the stability of public markets. Insights from public companies can also guide venture capital decisions and identify successful exit opportunities. Together, these strategies create a more resilient investment portfolio adaptable to changing market conditions.
Performance Snapshot
Year to date through September 30, 2026 · Strata net of fees (unaudited); indices are price returns
S&P 500
11.78%DJIA
5.92%Nasdaq
15.57%Strata
21.31%37.96%
Annualized Since Inception
+53.36%
Since Inception
−4.06%
Q3 2026 Return
$4.8M
Fund NAV
Jun 2, 2025
Inception
Source: internal fund accounting, as of September 30, 2026. Since-inception figure covers June 2, 2025 – September 30, 2026; FY2025 audited (Jones Simkins LLC), later periods unaudited. Risk statistics available upon request. Past performance is not indicative of future results.
Target Sectors
These technologies serve as foundational enablers across our portfolio—accelerating discovery, optimizing systems, and unlocking capabilities previously impossible.
Space Tech
Satellite infrastructure, launch economics, and orbital services are at an inflection point. We target companies enabling the $1.8T space economy.
Life Sciences
AI is revolutionizing drug discovery, diagnostics, and precision medicine. We invest in platforms leveraging computational biology.
Advanced Materials
Quantum and AI unlock novel materials for batteries, semiconductors, and sustainable manufacturing.
Nuclear Energy
Next-gen nuclear—including SMRs and fusion—represents critical baseload for an AI-powered world.
Track Record
Representative Investments
15
Unicorns Backed
80+
Portfolio Companies
27.5%
IRR Across Vehicles
Company
Sector
Status
Lyft
Transportation
IPO
Circle
Digital Currency
IPO
Lemonade
Insurtech
IPO
Appetas
Restaurant Tech
ACQUIRED
Paige AI
Medical AI
ACQUIRED
Stackfolio
Fintech
ACQUIRED
PsiQuantum
Quantum Computing
ACTIVE
Lightmatter
Photonic Computing
ACTIVE
Zipline
Logistics & Delivery
ACTIVE
Ripple
Blockchain Payments
ACTIVE
Axiom Space
Commercial Space
ACTIVE
Privateer
Space Data
ACTIVE
Hexembio
Biotechnology
ACTIVE
Junevity
Longevity
ACTIVE
Featured Investments
Circle Internet Financial
NYSE: CRCL · June 2025
We acquired our position in 2018. The company went public in June 2025, raising $1B at a valuation that represented 16x growth from our entry. Shares doubled on debut.
Co-investors: Goldman Sachs, BlackRock, Sequoia Capital
PsiQuantum
$3B → $7B2.3×
We built our position at a $3B valuation. The company is now backed by Nvidia and others at $7B. PsiQuantum is developing the first utility-scale quantum computer.
Co-investors: Nvidia, BlackRock, M12 (Microsoft)
Lightmatter
$450M → $4.4B9.8×
We built our position at $450M. Lightmatter's photonic chips enable dramatically faster and more energy-efficient AI computing.
Co-investors: GV (Google Ventures), Fidelity, Viking Global
Fund Infrastructure
Equity Capital Markets
Active institutional relationships with top-tier investment banks, providing priority access to IPO allocations, secondary offerings, and pre-IPO private placements across our core sectors.
Goldman Sachs
Equity syndicate & IPO allocation access
JP Morgan
Equity syndicate & IPO allocation access
Morgan Stanley
Equity syndicate & IPO allocation access
Bank of America Merrill Lynch
Post-IPO lockup execution & block trades
Service Providers
Prime Broker & Custodian
Oppenheimer & Co. Inc.
Full-service custody, trade execution, and investor account services
Auditor
Jones Simkins LLC
Independent annual audit and financial statement preparation
Legal Counsel
Sadis & Goldberg LLP
Fund formation, regulatory compliance, and ongoing legal advisory
Terms
Participation Framework
Strata is an evergreen investment fund designed to compound capital continuously across both public and private technology markets. The fund integrates liquid equity exposure, IPO allocations, and high-conviction private investments within a single vehicle, allowing investors to participate in innovation at every stage of maturity. This structure replaces the traditional vintage-cycle venture model with a unified, ongoing strategy that adapts quickly to market conditions.
Strata's participation framework spans two complementary domains. In public markets, the fund leverages its relationships with Goldman Sachs, J.P. Morgan, Morgan Stanley, and Bank of America to access IPOs, follow-on blocks, and listed technology equities. On the private side, Strata selectively invests in AI-driven and deep-tech companies—particularly in healthcare—where scientific and commercial trajectories show strong potential. This dual-path approach captures innovation from early private inflection points through public-market realization.
Strata offers institutional discipline with greater flexibility than traditional venture funds. A substantial portion of the portfolio is held in liquid public positions, and investors have an annual redemption window through which they may withdraw from the liquid portion of the fund. This design provides exposure to long-term private innovation while maintaining a predictable liquidity mechanism that aligns with investor planning needs.
Strata follows the industry-standard hedge fund fee structure: 2% management fee and 20% performance allocation, with no onboarding fees and no sales-load fees. According to Goldman Sachs' 2026 survey, investors are increasingly comfortable with this fee structure when performance justifies it. This transparent framework reinforces strong GP–LP alignment and supports long-term compounding.
Media
Expert Commentary
Circle IPO Analysis
Matt Oguz discusses Circle's public debut on Bloomberg Television · June 2025
Investor FAQ
Strata by Venture Science/ Investor FAQ
What is Strata?
Venture Science's flagship hybrid fund — an evergreen Delaware LP combining private venture positions with selective public-market and IPO/ECM participation across AI, quantum, space, healthcare, and energy.
Is Strata offering direct access to the SpaceX IPO?
No. Strata is not offering SpaceX shares. A widely anticipated SpaceX listing is one of several opportunities the fund would evaluate under its ECM/IPO mandate.
How would Strata gain exposure to a SpaceX listing?
If the fund secures and elects an allocation, that position sits inside the portfolio alongside other holdings. LPs own a pro-rata interest in the whole fund — no need to source or subscribe to the deal directly.
What if Strata doesn't receive a SpaceX allocation?
Marquee IPO allocations are competitive and never guaranteed. Strata's returns are built on a diversified portfolio and a disciplined process — not any single name.
Why invest through Strata rather than buying SpaceX after it lists?
A post-listing purchase gives you one stock at market price. Strata offers a managed, diversified portfolio with private venture upside, selective IPO access, and a decision-science framework — track record includes the Circle IPO (NYSE: CRCL). Past performance is not indicative of future results.
Where can I buy SpaceX shares directly?
If and when SpaceX lists, shares would be available through your brokerage like any public stock — a separate decision from investing in Strata.
Who is eligible to invest?
Accredited investors and qualified purchasers, including family offices, endowments, and institutional allocators. Accreditation verification is part of the subscription process.
What is the minimum investment?
$100,000 initial subscription. Full fee and term details are in the PPM.
How and when can I subscribe?
Introductory call → review of PPM and subscription documents → accreditation verification and paperwork. Reach out and we'll walk through current timing.
Once I invest, can I exit?
Strata is evergreen with annual redemption windows. Each contribution carries a 12-month lock-up; redemptions require advance notice and are subject to fund-level gates and the terms of the PPM and LPA.
What are the principal risks?
Significant risk, including loss of capital, illiquidity, and no guaranteed allocation in any offering. Review the PPM in full and consult your advisors.
Get in Touch
Discuss IPO Access
To discuss IPO access, allocation strategy, or investment in Strata, reach out directly. We work with qualified investors seeking institutional-grade exposure to high-demand technology offerings.
Matt Oguz
Managing Partner